Europe Antibiotics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Antibiotics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Antibiotics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Antibiotics Market Regional Analysis

6.2 Europe Antibiotics Market Revenue 2017-2027 (US$ Million)

6.3 Europe Antibiotics Market Forecast Analysis

7. Europe Antibiotics Market Analysis – by Drug Class

7.1 Sulfonamides

7.1.1 Overview
7.1.2 Sulfonamides: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Aminoglycosides

7.2.1 Overview
7.2.2 Aminoglycosides: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Carbapenem

7.3.1 Overview
7.3.2 Carbapenem: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Macrolides

7.4.1 Overview
7.4.2 Macrolides: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.5 Fluoroquinolones

7.5.1 Overview
7.5.2 Fluoroquinolones: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.6 Penicillin

7.6.1 Overview
7.6.2 Penicillin: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.7 Cephalosporin

7.7.1 Overview
7.7.2 Cephalosporin: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Antibiotics Market Analysis – by Action Mechanism

8.1 Mycolic Acid Inhibitors

8.1.1 Overview
8.1.2 Mycolic Acid Inhibitors: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 RNA Synthesis Inhibitors

8.2.1 Overview
8.2.2 RNA Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 DNA Synthesis Inhibitors

8.3.1 Overview
8.3.2 DNA Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Protein Synthesis Inhibitors

8.4.1 Overview
8.4.2 Protein Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Cell Wall Synthesis Inhibitors

8.5.1 Overview
8.5.2 Cell Wall Synthesis Inhibitors: Europe Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Antibiotics Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Antibiotics Market Breakdown, by Key Country, 2020 and 2027 (%)
9.2.1.1 Europe Antibiotics Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.1.1 UK: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.1.2 UK: Europe Antibiotics Market Breakdown, by Action Mechanism

9.2.1.2 Germany: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.2.1 Germany: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.2.2 Germany: Europe Antibiotics Market Breakdown, by Action Mechanism

9.2.1.3 France: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.3.1 France: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.3.2 France: Europe Antibiotics Market Breakdown, by Action Mechanism

9.2.1.4 Russia: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.4.1 Russia: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.4.2 Russia: Europe Antibiotics Market Breakdown, by Action Mechanism

9.2.1.5 Italy: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.5.1 Italy: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.5.2 Italy: Europe Antibiotics Market Breakdown, by Action Mechanism

9.2.1.6 Rest of Europe: Europe Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Antibiotics Market Breakdown, by Drug Class
9.2.1.6.2 Rest of Europe: Europe Antibiotics Market Breakdown, by Action Mechanism

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 GlaxoSmithKline plc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Sanofi

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Novartis AG

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Bayer AG

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Pfizer Inc

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Antibiotics Market